Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor.
Konstantinos EvmorfopoulosGeorgios ChasiotisAlexandros BarbatisIoannis ZachosGeorge N KouvelosMetaxia BarekaPanagiotis J VlachostergiosEleni ArnaoutoglouVassilios TzortzisMiltiadis MatsagkasPublished in: Current oncology (Toronto, Ont.) (2023)
Testicular germ cell tumors (TGCTs) are the leading cause of cancer-related death in males between the ages of 20 and 40. In the advanced stages, the combination of cisplatin-based chemotherapy and surgical excision of the remaining tumor can cure many of these patients. Vascular procedures may be required during retroperitoneal lymph node dissection (RPLND) in order to achieve the complete excision of all residual retroperitoneal masses. Careful assessment of pre-operative imaging and the identification of patients who could benefit from additional procedures are important for minimizing peri- and postoperative complications. We report on a case of a 27-year-old patient with non-seminomatous TGCT, who successfully underwent post-chemotherapy RPLND with additional infrarenal inferior vena cava (IVC) and complete abdominal aorta replacement using synthetic grafts.
Keyphrases
- germ cell
- inferior vena cava
- pulmonary embolism
- robot assisted
- locally advanced
- vena cava
- rectal cancer
- end stage renal disease
- lymph node
- pulmonary artery
- aortic valve
- newly diagnosed
- ejection fraction
- radical prostatectomy
- sentinel lymph node
- chronic kidney disease
- prostate cancer
- prognostic factors
- peritoneal dialysis
- chemotherapy induced
- early stage
- pulmonary arterial hypertension
- magnetic resonance imaging
- patient reported
- pulmonary hypertension
- patient reported outcomes
- aortic aneurysm
- photodynamic therapy
- fluorescence imaging